150 related articles for article (PubMed ID: 32030901)
1. Tumor volume and sphericity as predictors of local control after stereotactic radiosurgery for limited number (1-4) brain metastases from nonsmall cell lung cancer.
Ko PH; Kim HJ; Lee JS; Kim WC
Asia Pac J Clin Oncol; 2020 Jun; 16(3):165-171. PubMed ID: 32030901
[TBL] [Abstract][Full Text] [Related]
2. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases.
Likhacheva A; Pinnix CC; Parikh NR; Allen PK; McAleer MF; Chiu MS; Sulman EP; Mahajan A; Guha-Thakurta N; Prabhu SS; Cahill DP; Luo D; Shiu AS; Brown PD; Chang EL
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):656-61. PubMed ID: 22898384
[TBL] [Abstract][Full Text] [Related]
5. Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases.
Garsa AA; Badiyan SN; DeWees T; Simpson JR; Huang J; Drzymala RE; Barani IJ; Dowling JL; Rich KM; Chicoine MR; Kim AH; Leuthardt EC; Robinson CG
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):407-13. PubMed ID: 25084610
[TBL] [Abstract][Full Text] [Related]
6. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients.
Pontoriero A; Conti A; Iatì G; Mondello S; Aiello D; Rifatto C; Risoleti E; Mazzei M; Tomasello F; Pergolizzi S; De Renzis C
Neurosurg Rev; 2016 Jul; 39(3):495-504. PubMed ID: 27106896
[TBL] [Abstract][Full Text] [Related]
9. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
10. The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery.
Routman DM; Bian SX; Diao K; Liu JL; Yu C; Ye J; Zada G; Chang EL
Cancer Med; 2018 Mar; 7(3):757-764. PubMed ID: 29441722
[TBL] [Abstract][Full Text] [Related]
11. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
12. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
13. Impact of time of day on outcomes after stereotactic radiosurgery for non-small cell lung cancer brain metastases.
Badiyan SN; Ferraro DJ; Yaddanapudi S; Drzymala RE; Lee AY; Silver SA; Dyk P; DeWees T; Simpson JR; Rich KM; Robinson CG
Cancer; 2013 Oct; 119(19):3563-9. PubMed ID: 23839874
[TBL] [Abstract][Full Text] [Related]
14. Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases.
Nardone V; Nanni S; Pastina P; Vinciguerra C; Cerase A; Correale P; Guida C; Giordano A; Tini P; Reginelli A; Cappabianca S; Pirtoli L
Strahlenther Onkol; 2019 Aug; 195(8):734-744. PubMed ID: 31123785
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery.
Gao HX; Huang SG; Du JF; Zhang XC; Jiang N; Kang WX; Mao J; Zhao Q
Int J Biol Sci; 2018; 14(14):2065-2072. PubMed ID: 30585269
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
17. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
Bougie E; Masson-Côté L; Mathieu D
World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
[TBL] [Abstract][Full Text] [Related]
18. Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision.
de Azevedo Santos TR; Tundisi CF; Ramos H; Maia MA; Pellizzon AC; Silva ML; Fogaroli RC; Chen MJ; Suzuki SH; Dias JE; Sanematsu PI; de Castro DG
Radiat Oncol; 2015 Mar; 10():63. PubMed ID: 25884621
[TBL] [Abstract][Full Text] [Related]
19. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
20. Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
Wolf A; Kvint S; Chachoua A; Pavlick A; Wilson M; Donahue B; Golfinos JG; Silverman J; Kondziolka D
J Neurosurg; 2018 Jan; 128(1):23-31. PubMed ID: 28298015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]